
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 49
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT01536691 | Ramosetron, Aprepitant and Dexamethasone Versus Ondansetron, Aprepitant and Dexamethasone | ||
NCT04761744 | A Phase II Study of Nivolumab in Patients With Genetic Alterations in DNA Damage Repair and Response Who Progressed After Standard Treatment for Metastatic Solid Cancers | ||
NCT06083662 | Neratinib and Trastuzumab Biosimilar in Patients with HER2 Mutated Advanced Solid Cancers | ||
NCT01352494 | Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast Cancer | ||
NCT03518502 | Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis | ||
NCT05079503 | Gut Microbiome and Its Immune Modulation in Locally Advanced Rectal Cancer | ||
NCT00818090 | Paclitaxel and Cisplatin for Thymic Neoplasm | ||
NCT04753203 | Alpelisib and Capecitabine in Patients With PIK3CA Mutant mCRC Patients | ||
NCT04077255 | EGFR-targeted Therapy for Gastric Cancer | ||
NCT04751955 | A Phase lb/ll, Open Label, Single Arm Study With Olinvacimab and Capecitabine in mCRC Patients (OLCAP) | ||
NCT03975179 | Omitting vs. Doing Intraoperative Frozen Section Biopsy for Margin Status in Breast Conserving Surgery | ||
NCT00912938 | Evaluate the Relationship of Bone Remodeling Markers for Skeletal Complications in Metastatic Breast Cancer Patients | ||
NCT03292250 | Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)] | ||
NCT03414814 | Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutation | ||
NCT00343668 | S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer | ||
NCT00287768 | Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer | ||
NCT00595348 | Korean Hereditary Breast Cancer Study | ||
NCT00912639 | A Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients With Taxane-Pretreated Recurrent Breast Cancer | ||
NCT00912548 | Evaluating the Role of the Addition of Ovarian Function Suppression (OFS) to Tamoxifen in Young Women | ||
NCT00527930 | Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast Cancer | ||
NCT04116125 | Omitting Biopsy of SEntinel Lymph Node With Radiation After Neoadjuvant Chemotherapy in Breast Cancer (OBSERB) Trial | ||
NCT05904457 | A Phase II Stydy of Bevacizumab Plus Erlotinib in Patients for Krebs Cycle Altered Cancer | ||
NCT04247633 | High Risk ER+HER2- T1-2N0-1 Early Breast Cancer With Palbociclib Plus Endocrine Therapy(HIPEx) | ||
NCT01741116 | Dovitinib(TKI258) in Patients With Castration-resistant Prostate Cancer | ||
NCT04061863 | Nivolumab and Eribulin in HER2 Negative Metastatic Breast Cancer | ||
NCT00913016 | Assessment of Quality of Life, Bone Density and Safety in Postmenopausal Breast Cancer Patients With Letrozole Therapy | ||
NCT01224652 | Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapy | ||
NCT03193788 | Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy | ||
NCT00973037 | CYP2D6 Genotype on the Clinical Effect of Tamoxifen | ||
NCT05525858 | KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II | ||
NCT00561119 | Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer | ||
NCT06446570 | Phase II Study of Durvalumab(MEDI4736) + Tremelimumab in Pulmonary Sarcomatoid Carcinoma | ||
NCT02273375 | Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC | ||
NCT01196559 | Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer | ||
NCT03296306 | Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma | ||
NCT00819559 | Preoperative Chemoradiotheray for Rectal Cancer | ||
NCT03423199 | PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY | ||
NCT01593293 | Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell Lung Cancer | ||
NCT01069211 | Clinical Outcomes After Letrozole Treatment According to the Estrogen Receptor Expression in Postmenopausal Women | ||
NCT01622361 | Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer | ||
NCT06237205 | Genome-Based Assessment of Niraparib (ZEJULA®) Efficacy in Advanced Solid TumorS With Homologous Recombination Deficiency | ||
NCT01072318 | Extended Adjuvant Treatment With Letrozole in Breast Cancer Who Complete 5 Years of Toremifene | ||
NCT02114359 | Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer | ||
NCT04202328 | T-DM1 in HER2-positive Metastatic/Relapsed Breast Cancer | ||
NCT01351597 | A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast Cancer | ||
NCT00830245 | A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung Cancer | ||
NCT04938583 | Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer | ||
NCT03698383 | Phase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast Cancer | ||
NCT01952951 | Preoperative Chemoradiation Followed by Chemotherapy for Locally Advanced Rectal Cancer |